Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

about

Concept of the pathogenesis and treatment of cholelithiasis.Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions.Gallstones in New Zealand: composition, risk factors and ethnic differences.

P2860

Q35809361-D0C44573-3DDC-44BA-81E0-7C92E0EAD818 Q37951499-7AE9ADF0-21BF-4A73-967E-8883B572DF36 Q45216053-460CC691-4B52-4DFC-BB52-9C268272DE11

P2860

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

Item

http://www.wikidata.org/entity/Q42852539

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@en

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@nl

type

Item

label

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@en

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@nl

prefLabel

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@en

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@nl

P1476

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

@en

P2093

Mohamed H Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men

Gallstone disease: Epidemiology of gallbladder stone disease.

Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions.

Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic).

Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).

Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.

Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.

Hepatic insulin resistance directly promotes formation of cholesterol gallstones.

Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.

P304

1555-1557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3748/WJG.V16.I13.1555

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42769410

http://www.w3.org/2001/XMLSchema#string

P698

20355232

http://www.w3.org/2001/XMLSchema#string

P932

2848362

http://www.w3.org/2001/XMLSchema#string

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

about

P2860

P2860

Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932